Subscribe
Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

JAMA Editor’s Summary

Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

Editor's Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue
March 10, 2015

Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

Editor’s Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Cultivating Resilience During Times of Crisis and Existential Threat Keith interviews Dr. Chris Recinos, the CEO and founder of Nurse Leader Network, regarding mental health, adaptive and maladaptive mechanisms of resilience, and conscious self-development.